1. The landscape of miRNA-related ceRNA networks for marking different renal cell carcinoma subtypes
   Liu Qin et al, 2018 CrossRef
2. Molecular Mechanisms in Clear Cell Renal Cell Carcinoma: Role of miRNAs and Hypermethylated miRNA Genes in Crucial Oncogenic Pathways and Processes
   Eleonora A. Braga et al, 2019, Front. Genet. CrossRef
3. Upregulated lncRNA-UCA1 contributes to metastasis of bile duct carcinoma through regulation of miR-122/CLIC1 and activation of the ERK/MAPK signaling pathway
   Lei Kong et al, 2019, Cell Cycle CrossRef
4. MicroRNA‐92b‐3p is a prognostic oncomiR that targets TSC1 in clear cell renal cell carcinoma
   Cong Wang et al, 2020, Cancer Sci CrossRef
5. Relationship between apical junction proteins, gene expression and cancer
   Lorenza González-Mariscal et al, 2020, Biochimica et Biophysica Acta (BBA) - Biomembranes CrossRef
6. MicroRNA‑122 acts as tumor suppressor by targeting TRIM29 and blocking the activity of PI3K/AKT signaling in nasopharyngeal carcinoma in�vitro
   Yan Yang et al, 2018, Mol Med Report CrossRef
7. Clinical value of miRNA‑122 in the diagnosis and prognosis of various types of cancer
   Meiyu Dai et al, 2019, Oncol Lett CrossRef
8. MicroRNA Signature in Renal Cell Carcinoma
   Soudeh Ghafouri-Fard et al, 2020, Front. Oncol. CrossRef
9. Systematic Analysis of microRNA Biomarkers for Diagnosis, Prognosis, and Therapy in Patients With Clear Cell Renal Cell Carcinoma
   Guiyun Cheng et al, 2020, Front. Oncol. CrossRef
10. Detection of urinary miRNAs for diagnosis of clear cell renal cell carcinoma
    Giovanni Cochetti et al, 2020, Sci Rep CrossRef
11. The long non-coding RNA NNT-AS1 promotes clear cell renal cell carcinoma progression via regulation of the miR-137/ Y-box binding protein 1 axis
    Yadi Zhou et al, 2021, Bioengineered CrossRef
12. Insight into microRNAs-Mediated Communication between Liver and Brain: A Possible Approach for Understanding Acute Liver Failure?
    Karolina Orzeł-Gajowik et al, 2021, IJMS CrossRef
13. Applications of noncoding RNAs in renal cancer patients
    Eman A. Toraih et al, 2022 CrossRef
14. A novel nine-microRNA-based model to improve prognosis prediction of renal cell carcinoma
    Chen Xu et al, 2022, BMC Cancer CrossRef
15. Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients
    Ashraf Y. Elfert et al, 2022, Front. Mol. Biosci. CrossRef
16. MetastamiRs in Renal Cell Carcinoma: An Overview of MicroRNA Implicated in Metastatic Kidney Cancer
    Jonathan Xu et al, 2022 CrossRef
17. Prenatal arsenic exposure stymies gut butyrate production and enhances gut permeability in post natal life even in absence of arsenic deftly through miR122-Occludin pathway
    Mainak Chakraborty et al, 2022, Toxicology Letters CrossRef
18. Evaluation of Cellular miR-122 Expression in Association with the Presence of Varicella-Zoster Virus among Central Nervous System Tumors
    Aida Abbasi et al, 2022, Int J Cancer Manag CrossRef
19. MiR-24-1-5p Hinders Malignant Phenotypes of Clear Cell Renal Cell Carcinoma by Targeting SHOX2
    Jueyi Zhou et al, 2023, Biochem Genet CrossRef
20. Cytolethal distending toxin B inoculation leads to distinct gut microtypes and IBS-D-like microRNA-mediated gene expression changes in a rodent model
    Gabriela Leite et al, 2024, Gut Microbes CrossRef
21. SLFN11 promotes clear cell renal cell carcinoma progression via the PI3K/AKT signaling pathway
    He-Xi Wang et al, 2024, Med Oncol CrossRef
22. The Impact of miR-122 on Cancer
    Shijie Wu et al, 2024, CPB CrossRef
23. A Potential Role of MicroRNA in the Renal Cancer and Its Tumor Microenvironment
    Daniel Chikere Ali et al, 2025, ann urol oncol CrossRef